Krystal Biotech, Inc. KRYS
5 trading plans running, 19 Form 144 notices for $94.6M
10-Q, 10-K and Form 144What KRYS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Aug 29, 2023 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Laurent Goux Executive Vice President, Head of International |
Adopted 10b5-1 plan | Sep 10, 2026 | 10-Q Nov 2, 2026 | ||
What the company wroteOn September 10, 2026, Laurent Goux, our Executive Vice President, Head of International, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 3,045 shares of our common stock to be acquired upon the exercise of vested stock options, subject to certain conditions. The trading arrangement will terminate on September 10, 2027, subject to early termination in accordance with its terms, including upon the completion of the sale of all of the shares of our common stock subject to the trading arrangement. | |||||
| Kathryn Romano Executive Vice President & Chief Accounting Officer |
Adopted 10b5-1 plan | Aug 31, 2026 | 10-Q Nov 2, 2026 | ||
What the company wroteOn August 31, 2026, Kathryn Romano, our Executive Vice President & Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 11,527 shares of our common stock (including up to 10,927 shares to be acquired upon the exercise of vested stock options), the exercise of vested stock options for up to 1,573 shares of our common stock to be held by Ms. Romano, and a charitable gift of up to 1,163 shares of our common stock, in each case subject to certain conditions. The trading arrangement will terminate on December 31, 2027, subject to early termination in accordance with its terms, including upon the completion of all transactions contemplated by the trading arrangement. | |||||
| Daniel Janney directors |
Ended 10b5-1 plan | Mar 9, 2026 | 10-Q May 4, 2026 | ||
What the company wroteOn March 9, 2026, Daniel Janney, one of our directors, terminated a Rule 10b5-1 trading arrangement that was originally adopted on November 25, 2025. The Rule 10b5-1 trading arrangement was terminated during the Company’s unrestricted trading window and at a time when Mr. Janney was not in possession of material, non-public information about the Company. 71,964 shares of our common stock were sold under the Rule 10b5-1 trading arrangement prior to termination of the arrangement. | |||||
| Daniel Janney Board of Directors |
Adopted 10b5-1 plan | Nov 25, 2025 | 10-K Feb 17, 2026 | ||
What the company wroteOn November 25, 2025, Daniel Janney, a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 90,000 shares of the Company’s common stock, a portion of which will be issued upon exercise of stock options that if not exercised will expire in 2026. The Rule 10b5-1 trading arrangement will continue until November 5, 2026, subject to early termination in accordance with the terms of the Rule 10b5-1 trading arrangement, including upon completion of the sale of all of the shares of the Company’s common stock subject to the Rule 10b5-1 trading arrangement. | |||||
| Kathryn Romano Chief Accounting Officer |
Adopted 10b5-1 plan | Nov 6, 2025 | 10-K Feb 17, 2026 | ||
What the company wroteOn November 6, 2025, Kathryn Romano, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 20,000 shares of the Company’s common stock and a gift of up to 750 shares of the Company’s common stock. The Rule 10b5-1 trading arrangement will continue until August 31, 2026, subject to early termination in accordance with the terms of the Rule 10b5-1 trading arrangement, including upon completion of the sale of all of the shares of the Company’s common stock subject to the Rule 10b5-1 trading arrangement. | |||||
| Krish Krishnan Chief Executive Officer and Chairman of our Board of Directors |
Adopted 10b5-1 plan | Sep 4, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteOn September 4, 2025, Krish Krishnan, our Chief Executive Officer and Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement (the “Trading Plan”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock, subject to certain conditions. The end date of the Trading Plan is December 4, 2026, subject to early termination in accordance with the terms of the Trading Plan, including upon completion of the sale of all of the shares of our Common Stock subject to the Trading Plan. | |||||
| Suma Krishnan President and a member of our Board of Directors |
Adopted 10b5-1 plan | Sep 4, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteOn September 4, 2025, Suma Krishnan, our President and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement (the “Trading Arrangement”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock, subject to certain conditions. The end date of the Trading Arrangement is December 4, 2026, subject to early termination in accordance with the terms of the Trading Arrangement, including upon completion of the sale of all of the shares of our Common Stock subject to the Trading Arrangement. | |||||
| Kathryn Romano Chief Accounting Officer |
Adopted 10b5-1 plan | Nov 18, 2024 | 10-K Feb 19, 2025 | ||
What the company wroteOn November 18, 2024, Kathryn Romano, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for (1) the exercise of 5,000 stock options and sale of the associated shares of common stock issued to Ms. Romano until the earlier of execution of all trades or August 20, 2025, and (2) the sale on February 26, 2025 of up to 750 shares of common stock issued to Ms. Romano pursuant to the vesting of a RSA award on February 26, 2025. | |||||
| Krish Krishnan Chief Executive Officer and Chairman of our Board of Directors |
Adopted 10b5-1 plan | Jun 14, 2024 | 10-Q Aug 5, 2024 | ||
What the company wroteOn June 14, 2024, Krish Krishnan, our Chief Executive Officer and Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 13, 2025. | |||||
| Suma Krishnan President, R&D and a member of our Board of Directors |
Adopted 10b5-1 plan | Jun 14, 2024 | 10-Q Aug 5, 2024 | ||
What the company wroteOn June 14, 2024, Suma Krishnan, our President, R&D and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 13, 2025. | |||||
| Kathryn Romano Chief Accounting Officer |
Adopted 10b5-1 plan | Aug 29, 2023 | 10-Q Nov 6, 2023 | ||
What the company wroteOn August 29, 2023, Kathryn Romano, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 25,000 shares of our Common Stock until June 28, 2024. | |||||
| Krish Krishnan Chief Executive Officer and Chairman of our Board of Directors |
Adopted 10b5-1 plan | Jun 12, 2023 | 10-Q Aug 7, 2023 | ||
What the company wroteOn June 12, 2023, Krish Krishnan, our Chief Executive Officer and Chairman of our Board of Directors,adopted a Rule 10b5 - 1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5 - 1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 11, 2024. | |||||
| Suma Krishnan President, R&D and a member of our Board of Directors |
Adopted plan | Jun 12, 2023 | 10-Q Aug 7, 2023 | ||
What the company wroteOn June 12, 2023, Suma Krishnan, our President, R&D and a member of our Board of Directors, adopted a Rule 10b5 - 1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5 - 1(c) under the Exchange Act for the sale of up to 100,000 shares of our Common Stock until September 11, 2024. | |||||
| John Thomas Executive Vice President, General Counsel, and Corporate Secretary |
Adopted 10b5-1 plan | – | 10-Q May 4, 2026 | ||
What the company wroteOn February 3, 2026, John Thomas, our Executive Vice President, General Counsel, and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement (the “Trading Plan”) that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 1,903 shares of our common stock, subject to certain conditions. The end date of the Trading Plan is December 31, 2026, subject to early termination in accordance with the terms of the Trading Plan, including upon completion of the sale of all of the shares of our common stock subject to the Trading Plan. | |||||
Show the other 6 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Sep 4, 2026 | SUMA KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $9.3M |
| Sep 4, 2026 | KRISH KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $9.3M |
| Aug 14, 2026 | Dino A. Rossi Director |
25,000 | $8.3M |
| Jun 25, 2026 | Thomas John Charles Officer |
1,000 | $347K |
| Jun 4, 2026 | SUMA KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $7.5M |
| Jun 4, 2026 | KRISH KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $7.5M |
| May 26, 2026 | Thomas John Charles Officer |
642 | $194K |
| Mar 4, 2026 | SUMA KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $6.6M |
| Mar 4, 2026 | KRISH KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $6.6M |
| Mar 2, 2026 | ROMANO KATHRYN Officer |
750 | $201K |
| Feb 27, 2026 | Daniel S Janney Director |
11,803 | $3.3M |
| Feb 26, 2026 | Daniel S Janney Director |
7,741 | $2.1M |
| Feb 25, 2026 | Daniel S Janney Director |
700 | $192K |
| Feb 24, 2026 | JANNEY DANIEL Director |
37,895 | $10.1M |
| Feb 24, 2026 | Daniel S Janney Director |
13,825 | $3.7M |
| Feb 19, 2026 | ROSSI DINO A Director |
18,950 | $5.0M |
| Feb 9, 2026 | ROMANO KATHRYN Officer |
12,500 | $3.5M |
| Dec 4, 2025 | KRISH KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $5.4M |
| Dec 4, 2025 | SUMA KRISHNAN Director, Officer, 10% Stockholder |
25,000 | $5.4M |
Show the other 11 notices
From the Form 144 XML filed with the SEC, since Dec 4, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KRYS/export.csv") into a cell.